GPS Wealth Strategies Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$64.7K Sell
1,200
-3,302
-73% -$159K 0.06% 192
2025
Q3
$203K Buy
4,502
+2
+0% +$93 0.02% 341
2025
Q2
$208K Buy
4,500
+341
+8% +$16.7K 0.02% 315
2025
Q1
$254K Sell
4,159
-589
-12% -$34.3K 0.03% 271
2024
Q4
$269K Sell
4,748
-659
-12% -$36.8K 0.03% 252
2024
Q3
$280K Sell
5,407
-8,938
-62% -$419K 0.04% 252
2024
Q2
$596K Buy
14,345
+156
+1% +$6.98K 0.09% 140
2024
Q1
$769K Sell
14,189
-456
-3% -$23.2K 0.12% 120
2023
Q4
$751K Sell
14,645
-1,113
-7% -$58.4K 0.14% 115
2023
Q3
$915K Buy
15,758
+682
+5% +$41.8K 0.18% 99
2023
Q2
$964K Sell
15,076
-514
-3% -$34.5K 0.18% 101
2023
Q1
$1.08M Buy
15,590
+465
+3% +$32.8K 0.22% 84
2022
Q4
$1.09M Buy
15,125
+390
+3% +$29.4K 0.33% 64
2022
Q3
$1.05M Buy
14,735
+263
+2% +$19.1K 0.26% 61
2022
Q2
$1.11M Buy
14,472
+2,900
+25% +$221K 0.29% 62
2022
Q1
$845K Buy
11,572
+5,652
+95% +$379K 0.19% 69
2021
Q4
$369K Buy
5,920
+277
+5% +$16.2K 0.08% 154
2021
Q3
$334K Sell
5,643
-25
-0.4% -$1.65K 0.08% 146
2021
Q2
$379K Buy
5,668
+400
+8% +$26.1K 0.1% 135
2021
Q1
$332K Buy
5,268
+100
+2% +$6.22K 0.1% 136
2020
Q4
$321K Buy
5,168
+475
+10% +$29.2K 0.11% 125
2020
Q3
$283K Buy
+4,693
New +$282K 0.11% 118

Other funds holding BMY

GPS Wealth Strategies Group's BMY Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Bristol-Myers Squibb (BMY) stake by 73% in Q4 2025, selling an estimated $159K and leaving 1,200 shares worth $64.7K. The position accounts for 0.06% of the portfolio, ranked #192.

GPS Wealth Strategies Group first reported a position in BMY in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.11M in Q2 2022. 2,456 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • GPS Wealth Strategies Group held 1,200 shares of Bristol-Myers Squibb worth $64.7K as of Q4 2025.
  • GPS Wealth Strategies Group sold 3,302 Bristol-Myers Squibb shares in Q4 2025, an estimated $159K.
  • Bristol-Myers Squibb made up 0.06% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #192 holding.
  • GPS Wealth Strategies Group first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 22 quarters since.
  • GPS Wealth Strategies Group's Bristol-Myers Squibb position peaked at $1.11M in Q2 2022.
  • 2,456 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.